PNEUMOCONIOSES DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND TREATMENT. Carlos Robalo Cordeiro

Similar documents
4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

Lung Transplantation A look Inside A Surgeon s Perspective

Wim Wuyts. Treatment of idiopathic interstitial pneumonias. March 12 th Interstitial lung diseases state of the art.

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

Lines and crackles. Making sense of ILD

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

DIAGNOSTIC NOTE TEMPLATE

Epidemiology and classification of smoking related interstitial lung diseases

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy

Silicosis in Turkish denim sandblasters

Case 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random

Dr. Heyam Awad Pathology sheet #5 cont. Restrictive lung diseases

Geert M. Verleden, MD, PhD, FERS. Medical Director Leuven Lung Transplant Program

Differential diagnosis

IPF and Asbestos Reserves Salvation or Damnation?

Bronchiectasis in Adults - Suspected

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

CIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT

Disclosures. Transplanting Interstitial Lung Disease. Lung Transplantation. Indications. I have nothing to disclose. Adult Lung Transplants

MEDICAL SURVEILLANCE FOR SILICA-RELATED DISEASE: THE COLLEGIUM RAMAZZINI RESPONDS TO OSHA S PROPOSED RULE HISTORICAL PERSPECTIVE

DISEASES OF THE RESPIRATORY SYSTEM LECTURE 5 DR HEYAM AWAD FRCPATH

STUDY OF PULMONARY ARTERIAL HYPERTENSION IN RESPIRATORY DISORDERS

Respiratory Pathology. Kristine Krafts, M.D.

TIMING FOR TRANSPLANT: ARE WE ALWAYS LATE?

WF RESPIRATORY SYSTEM. RESPIRATORY MEDICINE

Evolution of Surgical Therapies for End-Stage Cardiopulmonary Failure. Heart Failure at the Shoe XI October 5, 2012

Patient with IPF and no honeycombing on HRCT. Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens

HUT LUNG: One of the Effects of Household Air Pollution (HAP) Thomas V. Colby MD Professor of Pathology (Emeritus) Mayo Clinic Arizona

Interstitial Lung Disease ILD: Definition

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel

Diseases of the Lung and Respiratory Tract, Part I. William Bligh-Glover M.D. Department of Anatomy, CWRU

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

Definition, classification and epidemiology

COI: no conflicts of interest to declare

Jingcai Xing 1,2,, Xiji Huang 1,, Lijuan Yang 3, Yuewei Liu 1, Hai Zhang 1 and Weihong Chen 1. Journal of Occupational Health

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Manish Powari Regional Training Day 10/12/2014

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment

DISEASES OF THE RESPIRATORY SYSTEM 2017 DR HEYAM AWAD LECTURE 5: restrictive lung diseases, part 1: fibrosing lung diseases

Differential diagnosis

Déjà vu all over again

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD)

Chronic Diffuse Interstitial (Restrictive) Diseases. By: Shefaa Qa qa

The Workers Advisers Office (WAO)

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Tomodensitometric detection in pneumoconiosis due to amorphous silica: correlation between conditions of exposure and radiological patterns.

International consensus statement on idiopathic pulmonary fibrosis

Diagnostic challenges in IPF

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

Interstitial Lung Disease

INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF)

Current diagnostic recommendations for ILD: The multidisciplinary meeting TSANZSRS ASM

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 21/08I

The Berlaymont building. Are there measurable health effects associated with work in a building containing flocked asbestos?

Update on Therapies for Idiopathic Pulmonary Fibrosis. Outline

Idiopathic Pulmonary Fibrosis Treatable and Not Idiopathic

Role of Pirfenidone in Idiopathic Pulmonary Fibrosis - A Longitudinal Cohort Study

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

Particle Size and Dust Inhalation

Nintedanib and Pirfenidone: New Medications in the Management of Idiopathic Pulmonary Fibrosis

Liebow and Carrington's original classification of IIP

Acute and Chronic Lung Disease

Chapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

9/15/11. Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September Scleroderma. Hard skin

Annual Report on Silicosis in Michigan

Bill Davies PAC RRT. Dyspnea: Uncovering Restrictive lung Disorders in Your Setting

Restrictive lung diseases

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington

A Review of Interstitial Lung Diseases

Unpaid scientific collaborator & advisor with Veracyte, Inc.

Lung cancer case finding in COPD using low-dose CT

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

Case 1: Question. 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule

Disabling Silicosis Having Grave Prognosis- A Preventable Ancient Malady Still Prevalent in Modern Era - A Case Report & Review of the Subject

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

380 Annals New York Academy of Sciences

UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION!

Pulmonary Sarcoidosis - Radiological Evaluation

TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

CTD-related Lung Disease

Interstitial Lung Disease (ILD)

Occupational Lung Disease in South Africa

Annual Report on Silicosis in Michigan

Diagnosis of Respiratory Bronchiolitis associated interstitial lung disease

Non-neoplastic Lung Disease II

Parametric response mapping

Progress in Idiopathic Pulmonary Fibrosis

Content Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties

Guidelines for Diagnosis and Treatment of IPF

Lung Cancer - Suspected

WORKSHOP OF LUNG FUNCTION TEST. Dr. Lo Iek Long, Department of Respiratory Medicine, CHCSJ, Macau

punctiform type of coalworkers' In 1958 a stratified random sample of 300 miners and a private census in the Rhondda Fach in Glamorgan

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

Transcription:

PNEUMOCONIOSES DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND TREATMENT Carlos Robalo Cordeiro carlos.crobalo@gmail.com

Diagnosis 1 History of sufficient exposure to dust, in time and intensity/either occupational or environmental/markers of exposure 2 Compatible radiological features/structural pathology consistent 3 Exclusion of other competing diagnosis /confounders/diseases that mimic pneumoconiosis

Diagnosis 1 History of sufficient exposure to dust, in time and intensity/either occupational or environmental/markers of expousure Detailed occupational history Parents and spouses occupations Products and manner of manipulation Poor appreciation/exageration (compensation) Hobbies Objective evidence of exposure (pleural plaques/asbestos sputum,bal)

JMRR, male, 59 years-old Heavy smoker Shipyard worker

Bronchoalveolar Lavage in the diagnosis and management of Interstitial Lung Disease Keith C Meyer. Clin Pulm Med 2007, 14: 148-156

Bronchoalveolar Lavage in the diagnosis and management of Interstitial Lung Disease Keith C Meyer. Clin Pulm Med 2007, 14: 148-156

Bronchoalveolar Lavage in the diagnosis and management of Interstitial Lung Disease Keith C Meyer. Clin Pulm Med 2007, 14: 148-156

Bronchoalveolar Lavage in the diagnosis and management of Interstitial Lung Disease Keith C Meyer. Clin Pulm Med 2007, 14: 148-156

AJRCCM 2009, 179: 1043-1047

Bronchoalveolar Lavage in Occupational Lung Diseases C Robalo Cordeiro et al. Sem Respir Crit Care Med 2007, 28 : 504-513

Bronchoalveolar Lavage in Interstitial Lung Disease Costabel U et al. Curr Opin Pulm Med 2001, 7: 255-261

Occupational Diseases J. C. S., male, 62 years-old Progressive dyspnea and fatigue Restrictive ventilatory defect Professional contact with Asbestos

Occupational Diseases Identification of asbestos bodies > 1/ml C Robalo Cordeiro et al. Sem Respir Crit Care Med 2007, 28 : 504-513

Diagnosis 2 Compatible radiological features/structural pathology consistent ILO X-Ray classification

Diagnosis 2 Compatible radiological features/structural pathology consistent ILO X-Ray classification B reader Digital chest images ILO classification? HRCT scan more sensitive in specific features, differential diagnosis

Diagnosis 2 Compatible radiological features/structural pathology consistent Multidetector CT Denim-sandblasting-induced silicosis Low dose HRCT Lung cancer screening MRI Distinguish between progressive massive fibrosis and lung cancer PET scan Differentiate active inflammation and lung cancer from chronic changes

Diagnosis 3 Exclusion of other competing diagnosis /confounders/diseases that mimic pneumoconiosis IPF (smoking related and other ILD), CTD, Infections (miliary tuberculosis, fungal), Carcinomatosis, Confounders Cigarette smoking Granulomatous disease

Diagnosis Respiratory illness Past medical history Occupational history Smoking history Spirometry, lung volumes, DLCO

Clinical Case A.C.E, male, 64 years-old Granite/stone work Diagnosis 12 years ago Dispnoea Crackles on inspiration FVC 51%, DLCO 58% Clinically stable No treatment

Complications/Conditions associated Silicosis Tuberculosis, Coal-worker s pneumoconiosis Rheumatoid shadows (Caplan s syndrome) Asbestosis Lung cancer, Pulmonary Hipertension

Treatment No proven curative treatment for silicosis exists No evidence that any intervention alters the course of asbestosis

Silicosis - Treatment Inhalatory Therapy Alluminium Tetrandrine Polivinyl-pyridine-N-oxide Whole lung lavage Steroids/Immunossupressors/Pirfenidone (?) 02 Lung Transplant

Adult Lung Transplants Indications for Single Lung Transplants (Transplants: January 1995 June 2012) Alpha-1 COPD CF IPF IPAH Re-Tx Other* 34% 2% 1% 3% 10% 5% *Other includes: Pulmonary Fibrosis, Other: 4.0% Bronchiectasis: 0.4% Sarcoidosis: 1.9% Connective Tissue Disease: 1.1% OB (non-retx): 0.7% LAM: 1.0% Congenital Heart Disease: 0.4% Miscellaneous: 1.1% 44% 2013 JHLT. 2013 Oct; 32(10): 965-978

Adult Lung Transplants Indications for Bilateral/Double Lung Transplants (Transplants: January 1995 June 2012) Alpha-1 COPD CF IPF IPAH Re-Tx Other* 26% 17% 5% 2% 17% 6% *Other includes: Pulmonary Fibrosis, Other: 3.5% Bronchiectasis: 4.1% Sarcoidosis: 2.9% Connective Tissue Disease: 1.4% OB (non-retx): 1.3% LAM: 1.1% Congenital Heart Disease: 1.2% Miscellaneous: 1.8% 27% 2013 JHLT. 2013 Oct; 32(10): 965-978

Survival following lung transplantation for silicosis and other occupational lung diseases Singer JP1, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD Occup Med. 2012 Mar;62(2):134-7

Survival following lung transplantation for silicosis and other occupational lung diseases Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD Key points Lung transplantation for occupational lung diseases is relatively rare in the USA, representing 0.5% of all transplants performed. Subjects undergoing lung transplantation for occupational lung diseases appear to be at risk for poorer survival in the first posttransplant year. This first post-transplant year risk appears to be restricted to those subjects undergoing lung transplantation for non-silicotic occupational lung diseases. Occup Med. 2012 Mar;62(2):134-7

Silicosis - Prevention